Summary
Chlamydia trachomatis infections are exceedingly prevalent, and can be associated with significant sequelae. The major infections are urethritis, cervicitis, salpingitis, and ocular infection. Chlamydial genital infections present as syndromes, where C. trachomatis is one of the causes of the syndrome. Because specific laboratory diagnosis of a chlamydial infection is often not available, and even if available does not exclude the concurrent presence of other pathogens, therapy should usually be directed at all the major causes of the syndrome. Thus, although C. trachomatis is readily eradicated by tetracyclines, macrolides, sulphonamides, and rifampicin, for most situations tetracyclines are the drugs of choice. Penicillins have some activity when used in multiple- dose therapy, but are not reliable for eradication of chlamydiae. Aminoglycosides, nitroimidazoles, and the newer cephalosporins have minimal or no useful activity. Seven days of tetracycline hydrochloride 500mg 4 times daily or doxycycline 100mg twice daily are the optimum regimens for uncomplicated urethritis, cervicitis (except in pregnancy), and gonorrhoea. These regimens should be extended to 10 days for epididymitis and salpingitis. Additional antimicrobials should be added to the salpingitis regimen.
For chlamydial infection during pregnancy, erythromycin 500mg 4 times daily for 1 week or 250mg 4 times daily for 2 weeks should be utilised. Neonatal infection requires 2 to 3 weeks of systemic treatment with erythromycin. Inclusion conjunctivitis responds well to antimicrobials, but improved sanitation has a greater effect than antimicrobial therapy in the management of trachoma.
Similar content being viewed by others
References
Alexander, E.R.; Harrison, H.R.; Lewis, M.; Sim, D.A. and Podgore, J.K.: Strategies for prevention of infant chlamydial disease; in Mardh et al. (Eds) Chlamydial Infections, pp. 225–228 (Elsevier Biomedical Press, New York 1982).
Beem, M.O.; Saxon, E. and Tipple, M.A.: Treatment of chlamydial pneumonia of infancy. Pediatrics 63: 198–203 (1979).
Bell, T.A.; Sandstrom, I.N.; Fernau, K.J.; Kuo, C.C.; Chandler, J.W.; Wang, S.-P.; Foy, H.M. and Grayston, J.T.: Failure to eradicate infant Chlamydia trachomatis infection with a ten day course of oral erythromycin. Presented at the 1st Sexually Transmitted Diseases World Congress, San Juan, Puerto Rico, November 15–21, Abstract No. 50 (1981).
Black, S.B.; Grossman, M.; Cles, L. and Schachter, J.: Serologic evidence of chlamydial infection in children. Journal of Pediatrics 98: 65–67 (1981).
Blackman, H.J.; Yoneda, C.; Dawson, C.R. and Schachter, J.: Antibiotic susceptibility of Chlamydia trachomatis. Antimicrobial Agents and Chemotherapy 12: 673–677 (1977).
Bowie, W.R.: Treatment of chlamydial infections; in Mardh et al. (Eds) Chlamydial Infections, pp. 231–244 (Elsevier Biomedical Press, New York 1982).
Bowie, W.R.; Lee, C.K. and Alexander, E.R.: Prediction of efficacy of antimicrobial agents in treatment of infections due to Chlamydia trachomatis. Journal of Infectious Diseases 138: 655–659 (1978).
Bowie, W.R.; Manzon, L.M.; Borrie-Hume, C.J.; Fawcett, A. and Jones, H.D.: Efficacy of treatment regimens for lower urogenital Chlamydia trachomatis infection in women. American Journal of Obstetrics and Gynecology 142: 125–129 (1982).
Centers for Disease Control: Sexually transmitted disease: Treatment guidelines, 1982. Reviews of Infectious Diseases 4 (Suppl.): 729–746 (1982).
Coufalik, E.D.; Taylor-Robinson, D. and Csonka, G.W.: Treatment of nongonococcal urethritis with rifampicin as a means of defining the role of Ureaplasma urealyticum. British Journal of Venereal Diseases 55: 36–43 (1979).
Hammerschlag, M.R.; Chandler, J.W.; Alexander, E.R.; English, M.; Chiang, W.-T.; Koutsky, L.; Eschenbach, D.A. and Smith, J.R.: Erythromycin ointment for ocular prophylaxis of neonatal chlamydial infection. Journal of the American Medical Association 244: 2291–2293 (1980).
Holmes, K.K.: Acute epididymitis. Current Therapeutic Research 26: 738–744 (1979).
Hoshiwara, I.; Oster, H.B.; Harrna, L.; Cignetti, F.; Coleman, V.R. and Jawetz, E.: Doxycycline treatment of chronic trachoma. Journal of the American Medical Association 224: 220–223 (1973).
Johannisson, G.; Sernryd, A. and Lycke, E.: Susceptbility of Chlamydia trachomatis to antibiotics in vitro and in vivo. Sexually Transmitted Diseases 6: 50–57 (1979).
McCabe, M.E.; Fiumara, N.J. and McCormack, W.M.: Effect of three regimens for the treatment of gonorrhea on the incidence of postgonococcal urethritis. Presented at the 1st Sexually Transmitted Diseases World Congress, San Juan, Puerto Rico, November 15–21, Abstract No. 130 (1981).
Mourad, A.; Sweet, R.L.; Sugg, N. and Schachter, J.: Relative resistance to erythromycin in Chlamydia trachomatis. Antimicrobial Agents and Chemotherapy 18: 696–698 (1980).
Oriel, J.D.; Ridgway, G.L. and Tchamouroff, S.: Comparison of erythromycin stearate and oxytetracycline in the treatment of nongonococcal urethritis: Their efficacy against Chlamydia trachomatis. Scottish Medical Journal 22: 375–379 (1977).
Perine, P.L.; Andersen, A.J.; Krause, D.W.; Awoke, S.; Wang, S.-P.; Kuo, C.C. and Holmes, K.K.: Diagnosis and treatment of lymphogranuloma venereum in Ethiopia; in Nelson and Grass (Eds) Current Chemotherapy and Infectious Disease: Proceedings of the 11th International Congress of Chemotherapy and the 19th Interscience Conference on Antimicrobial Agents and Chemotherapy, Boston, Massachusetts, October 1–5, 1979, pp. 1280–1282 (American Society of Microbiology, Washington, DC 1980).
Rees, E.; Tait, I.A.; Hobson, D.; Karayiannis, P. and Lee, N.: Persistence of chlamydial infection after treatment for neonatal conjunctivitis. Archives of Disease in Children 56: 193–198 (1981).
Ridgway, G.L.; Owen, J.M. and Oriel, J.D.: The antimicrobial susceptibility of Chlamydia trachomatis in cell culture. British Journal of Venereal Diseases 54: 103–106 (1978).
Schachter, J.: Chlamydial infections. New England Journal of Medicine 298: 428–435, 490–495, 540–549 (1978).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bowie, W.R. Epidemiology and Therapy of Chlamydia trachomatis Infections. Drugs 27, 459–468 (1984). https://doi.org/10.2165/00003495-198427050-00005
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-198427050-00005